Tags: Drug.

C16 or PKRi is a drug which acts as a selective inhibitor of the enzyme double-stranded RNA-dependent protein kinase (PKR). It has been shown to effectively inhibit PKR function in vivo and has neuroprotective and nootropic effects in animal studies.

C16_structure.png
CAS number
608512-97-6
IUPAC name
68-Dihydro-8-(1H-imidazol-5-ylmethylene)-7H-pyrrolo[23-g]benzothiazol-7-one
PubChem
6490494

Loading...

This page contains content from the copyrighted Wikipedia article "C16 (PKR inhibitor)"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.